Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro).

H J Meulenbeld,E D van Werkhoven,J L L M Coenen,G J Creemers,O J L Loosveld,P C de Jong,A J Ten Tije,S D Fosså,M Polee,W Gerritsen,O Dalesio,R de Wit

European Journal of Cancer（2012）

引用 38|浏览27
暂无评分
关键词
Bisphosphonates,Bone metastases,Castration Resistant Prostate Cancer,Docetaxel,Risedronate
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要